ArticleJournal for the measurement of physical behaviour2023
Convergent validity of time in bed estimates from activPAL and Actiwatch in free-living youth and adults.
Article in Journal for the measurement of physical behaviour, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Sport training day affects adolescent athletes' sleep schedules.Frontiers in sports and active living · 2025Article
- Comparing Multiple Approaches to Estimate Physical Activity, Sedentary Behavior, and Sleep in Pregnancy.Journal for the measurement of physical behaviour · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Actiwatch devices are often used to estimate time in bed (TIB), but recently became commercially unavailable. Thigh-worn activPAL devices could be a viable alternative. We tested convergent validity between activPAL (CREA algorithm) and Actiwatch devices. Data were from free-living samples comprising 47 youth (3-16 valid nights/participant) and 42 adults (6-26 valid nights/participant) who wore both devices concurrently. On average, activPAL predicted earlier bedtimes and later risetimes compared to Actiwatch, resulting in longer overnight intervals (by 1.49 hours/night for youth and 0.67 hours/night for adults; both p < 0.001). TIB interruptions were predicted less commonly by activPAL (mean < 2 interruptions/night for both youth and adults) than Actiwatch (mean of 24-26 interruptions/night in both groups; both p < 0.001). Overnight intervals for both devices tended to overlap for lengthy periods (mean of 7.38 hours/night for youth and 7.69 hours/night for adults). Within these overlapping periods, the devices gave matching epoch-level TIB predictions an average of 87.9% of the time for youth and 84.3% of the time for adults. Most remaining epochs (11.8% and 15.1%, respectively) were classified as TIB by activPAL but not Actiwatch. Overall, the devices had fair agreement during the overlapping periods, but limited agreement when predicting interruptions, bedtime, or risetime. Future work should assess the criterion validity of activPAL devices to understand implications for health research. The present findings demonstrate that activPAL is not interchangeable with Actiwatch, which is consistent with their differing foundations (thigh inclination for activPAL versus wrist movement for Actiwatch).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.